Latest Publications

Share:

FDA Warning Letter to Curaleaf Inc.

The Food and Drug Administration (FDA), following up on its public concerns about the science, safety, effectiveness and quality of unapproved products containing cannabidiol (CBD), recently issued a warning letter to...more

Focus Newsletter - December 2014

In this issue: - ABC's of a Product Recall - Amazing Clients® Lumenpulse Inc. - A Bright Future for a Company That Is Lighting Up the World - Delaware Corporate Law Becomes More User-Friendly -...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide